News Formal

U.S. drug prices to rise in 2020 as companies prepare to charge more for Ibrance, Xeljanz, 200 others

  • 📰 HealthyWomen
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 68%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

Drugmakers on Wednesday hiked US list prices on more than 50 drugs. prescriptions

Expect to pay more for some prescription drugs in 2020 as pharmaceutical companies such as Pfizer, GlaxoSmithKline PLC and Sanofi SA will institute a price hike on over 200 drugs beginning Wednesday, according to 3 Axis Advisors, a healthcare data analysis firm.

The breast cancer medication Ibrance and arthritis medication Xeljanz, both manufactured by Pfizer, are expected to be around five percent more expensive. GlaxoSmithKline is expected to raise prices on approximately 30 of its products, including the COPD and asthma medication, Ellipta, and the cancer drug, Zejula. Pharmaceutical manufacturer Sanofi is expected to increase the price of 10 of its drugs.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 29. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tesla stock price could surge 23% in 2020 according to one analyst - Business InsiderJed Dorsheimer of Canaccord Genuity, raised his price target to $515 from $375 Thursday, saying electric vehicles will 'only accelerate in 2020.'
Source: BusinessInsider - 🏆 729. / 51 Read more »